STAT calls for input on mitochondrial replacement therapy used in fertility tourism

STAT is asking patients and clinicians to share their experiences with mitochondrial replacement techniques (MRT), sometimes called three-parent IVF, which are being marketed as a fertility option for older women.

Although MRT is prohibited in the United States, a for-profit industry has emerged that connects U.S. and European patients with clinics abroad where the procedure is performed.

The investigation notes that evidence for MRT’s effectiveness in treating infertility is limited, and the agency hopes the responses will shed light on how these clinics operate.

The call for information is part of STAT’s broader effort to examine reproductive technologies and inform policy discussions.